CRON - Cronos Group Inc.
2.62
0.020 0.763%
Share volume: 713,797
Last Updated: 03-04-2026
Pharmaceutical Products/Medicinal Chemicals:
2.32%
PREVIOUS CLOSE
CHG
CHG%
$2.60
0.02
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 1.109 B | 1.091 B | 1.184 B | 1.166 B | 1.154 B | 1.175 B | 1.178 B | 1.197 B | |
| Current Assets | 942.216 M | 935.278 M | 959.174 M | 936.113 M | 918.581 M | 927.147 M | 922.151 M | 944.086 M | |
| Inventories | 30.639 M | 29.182 M | 47.250 M | 33.149 M | 34.603 M | 42.142 M | 48.167 M | 46.750 M | |
| Other Current Assets | 19.398 M | 19.197 M | 8.971 M | 8.112 M | 8.089 M | 6.022 M | 2.873 M | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 40.000 M | 40.000 M | 40.000 M | 40.000 M | |
| Total Receivables | 30.787 M | 33.464 M | 33.593 M | 29.770 M | 31.757 M | 39.376 M | 38.172 M | 57.198 M | |
| Current Cash | 855.114 M | 848.189 M | 862.034 M | 858.805 M | 797.819 M | 794.416 M | 784.170 M | 791.794 M | |
| Total Non-current Assets | 40.279 M | 24.394 M | 2.900 M | 2.813 M | 2.755 M | 2.251 M | 11.443 M | 7.664 M | |
| Property Plant Equipment | 37.171 M | 36.964 M | 162.516 M | 133.189 M | 139.185 M | 150.243 M | 145.536 M | 145.865 M | |
| Other Assets | 129.148 M | 118.806 M | 62.443 M | 97.010 M | 96.061 M | 97.837 M | 110.723 M | 107.189 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.109 B | 1.091 B | 1.184 B | 1.166 B | 1.154 B | 1.175 B | 1.178 B | 1.197 B | |
| Total liabilities | 35.757 M | 35.256 M | 52.822 M | 55.330 M | 39.062 M | 45.021 M | 46.361 M | 54.181 M | |
| Total current liabilities | 33.419 M | 33.057 M | 39.564 M | 49.700 M | 33.048 M | 37.612 M | 41.067 M | 48.187 M | |
| Accounts Payable | 9.401 M | 7.840 M | 6.532 M | 16.973 M | 9.499 M | 12.136 M | 10.865 M | 11.640 M | |
| Other liabilities | 2.338 M | 2.199 M | 2.115 M | 2.066 M | 1.451 M | 1.869 M | 1.864 M | 1.905 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.338 M | 2.199 M | 2.115 M | 2.066 M | 1.451 M | 1.869 M | 1.864 M | 1.905 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.076 B | 1.059 B | 1.082 B | 1.064 B | 1.066 B | 1.082 B | 1.083 B | 1.094 B | |
| Common stock | 663.673 M | 665.677 M | 667.926 M | 669.879 M | 669.036 M | 666.614 M | 666.147 M | 662.983 M | |
| Retained earnings | 414.478 M | 405.650 M | 413.995 M | 457.709 M | 463.816 M | 424.080 M | 450.032 M | 447.756 M |